Esperion Therapeutics Inc. (ESPR)

36.52
0.29 0.80
NASDAQ : Health Technology
Prev Close 36.23
Open 36.11
Day Low/High 35.90 / 36.68
52 Wk Low/High 33.13 / 60.99
Volume 73.25K
Avg Volume 439.90K
Exchange NASDAQ
Shares Outstanding 27.17M
Market Cap 990.93M
EPS -7.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Notable Monday Option Activity: ESPR, SYNA, LL

Notable Monday Option Activity: ESPR, SYNA, LL

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Esperion Therapeutics Inc , where a total of 3,179 contracts have traded so far, representing approximately 317,900 underlying shares. That amounts to about 58.5% of ESPR's average daily trading volume over the past month of 543,035 shares.

Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors To Contact Law Firm For Possible Claims Against Officers And Directors

Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors To Contact Law Firm For Possible Claims Against Officers And Directors

NEW YORK, April 24, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating whether certain officers and directors of Esperion Therapeutics, Inc.

IBM's Pricey Red Hat Deal Helps Put Pep in Market's Step

IBM's Pricey Red Hat Deal Helps Put Pep in Market's Step

There is much talk that IBM is overpaying for Red Hat, but this deal is a net positive for the market as a whole.

First Week Of ESPR June 2019 Options Trading

First Week Of ESPR June 2019 Options Trading

Investors in Esperion Therapeutics Inc saw new options become available this week, for the June 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of ESPR January 2021 Options Trading

First Week Of ESPR January 2021 Options Trading

Investors in Esperion Therapeutics Inc saw new options begin trading this week, for the January 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 844 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ESPR November 16th Options Begin Trading

ESPR November 16th Options Begin Trading

Investors in Esperion Therapeutics Inc saw new options begin trading today, for the November 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 80 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Esperion Therapeutics, Inc. Of Class Action Lawsuit And Upcoming Deadline - ESPR

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Esperion Therapeutics, Inc. Of Class Action Lawsuit And Upcoming Deadline - ESPR

Pomerantz LLP announces that a class action lawsuit has been filed against Esperion Therapeutics, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Esperion Therapeutics, Inc. Of Class Action Lawsuit And Upcoming Deadline - ESPR

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Esperion Therapeutics, Inc. Of Class Action Lawsuit And Upcoming Deadline - ESPR

Pomerantz LLP announces that a class action lawsuit has been filed against Esperion Therapeutics, Inc.

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline In Class Action Lawsuit Filed Against Esperion Therapeutics, Inc.

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline In Class Action Lawsuit Filed Against Esperion Therapeutics, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP reminds Esperion Therapeutics, Inc.

ESPR EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Esperion Therapeutics, Inc. And A Lead Plaintiff Deadline Of July 6, 2018

ESPR EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Esperion Therapeutics, Inc. And A Lead Plaintiff Deadline Of July 6, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Michigan on behalf of investors who purchased Esperion Therapeutics, Inc.

INVESTOR ALERT: Kirby McInerney LLP Advises Esperion Therapeutics, Inc. (ESPR) Investors Of Potential Claims

INVESTOR ALERT: Kirby McInerney LLP Advises Esperion Therapeutics, Inc. (ESPR) Investors Of Potential Claims

The law firm of Kirby McInerney LLP announced today that a class action lawsuit has been filed in the United States District Court for the Eastern District of Michigan, against Esperion Therapeutics, Inc.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Esperion Therapeutics, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 6, 2018

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Esperion Therapeutics, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 6, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Esperion Therapeutics, Inc.

The Klein Law Firm Announces A Class Action Commenced On Behalf Of Esperion Therapeutics, Inc. Shareholders And A Lead Plaintiff Deadline Of July 6, 2018 (ESPR)

The Klein Law Firm Announces A Class Action Commenced On Behalf Of Esperion Therapeutics, Inc. Shareholders And A Lead Plaintiff Deadline Of July 6, 2018 (ESPR)

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Esperion Therapeutics, Inc.

Interesting ESPR Put And Call Options For October 19th

Investors in Esperion Therapeutics Inc saw new options become available today, for the October 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 148 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ESPR INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Esperion Therapeutics, Inc. And A Lead Plaintiff Deadline Of July 6, 2018

ESPR INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Esperion Therapeutics, Inc. And A Lead Plaintiff Deadline Of July 6, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Michigan on behalf of investors who purchased Esperion Therapeutics, Inc.

First Week Of ESPR July 20th Options Trading

Investors in Esperion Therapeutics Inc saw new options become available this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ESPR options chain for the new July 20th contracts and identified one put and one call contract of particular interest.

Kessler Topaz Meltzer & Check, LLP Announces Investor Class Action Lawsuit Filed Against Esperion Therapeutics, Inc.

Kessler Topaz Meltzer & Check, LLP Announces Investor Class Action Lawsuit Filed Against Esperion Therapeutics, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP announces that an investor class action lawsuit has been filed against Esperion Therapeutics, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Esperion Therapeutics, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 6, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Esperion Therapeutics, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 6, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Esperion Therapeutics, Inc.

ESPR ALERT: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors Of Important July 6 Deadline In Class Action

ESPR ALERT: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors Of Important July 6 Deadline In Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Esperion Therapeutics, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Esperion Therapeutics, Inc. (ESPR)

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Esperion Therapeutics, Inc. (ESPR)

The Klein Law Firm announces the commencement of an investigation of Esperion Therapeutics, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Esperion Therapeutics, Inc. (ESPR)

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Esperion Therapeutics, Inc. (ESPR)

The Klein Law Firm announces the commencement of an investigation of Esperion Therapeutics, Inc.

ESPR INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Esperion Therapeutics, Inc.

ESPR INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Esperion Therapeutics, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Esperion Therapeutics, Inc.

ESPR SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Esperion Therapeutics, Inc.

ESPR SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Esperion Therapeutics, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Esperion Therapeutics, Inc.